AFP reported that 2,250 people of various nations – from Great Britain, South Africa, Brazil and Poland will be recruited for the second and third phase of the tests. IN vaccine “vector” (adenoviral) technology is used, which is used in vaccines against Covid-19 worldwide.
Watch the video
Difficult time of restaurateurs. “There are tons of vacancies for which there is no answer”
–
“Testing of doses boosting existing vaccines and those for new variants is important to ensure that we are well prepared to deal with pandemi± coronavirus, said the director of the University of Oxford Vaccine Group Andrew Pollard.
Data from clinical trials will be submitted to vaccine availability regulators for evaluation in an accelerated process. If approved, a vaccine will be the first to be used against a specific variant of the coronavirus.
In May rz±d The British announced that clinical trials have begun to investigate the body’s immune response to the third dose of the Covid-19 vaccine due to the increase in infections with the Delta variant of the coronavirus.
Coronawirus: all current information and recommendations on gov.pl.
–
Related
